CD48 on blood leukocytes and in serum of asthma patients varies with severity.

scientific article

CD48 on blood leukocytes and in serum of asthma patients varies with severity. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/ALL.13082
P698PubMed publication ID27859399

P50authorPeter BraddingQ41855963
Clair BarberQ57329545
Roopesh Singh GangwarQ60327939
P2093author name stringS Holgate
A Chauhan
P Howarth
F Levi-Schaffer
M Seaf
Y Minai-Fleminger
R Eliashar
N Berkman
A Shikotra
A Gutgold
P2860cites worksCD48 is anti-inflammatory in Staphylococcus aureus Enterotoxin B-induced eosinophilic inflammation.Q40032051
Polymorphisms related to ORMDL3 are associated with asthma susceptibility, alterations in transcriptional regulation of ORMDL3, and changes in TH2 cytokine levels.Q40990818
Allergic host defencesQ41190858
The CD48 receptor mediates Staphylococcus aureus human and murine eosinophil activationQ41726277
Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 moleculesQ42755341
2B4 (CD244) is expressed and functional on human eosinophilsQ45195916
Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokinesQ28253247
Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritisQ28258148
Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48Q28574579
ORMDL3 promotes eosinophil trafficking and activation via regulation of integrins and CD48.Q30573228
Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptorsQ34345732
Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous diseaseQ34832426
Asthma and allergic inflammationQ35099497
CD48 is critically involved in allergic eosinophilic airway inflammationQ35855225
Asthma control or severity: that is the questionQ36734990
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patientsQ36765753
Assessment of asthma control and its impact on optimal treatment strategyQ36825049
Roles of CD48 in regulating immunity and toleranceQ36883146
Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3-like protein 1Q37056664
Mast cells and eosinophils: the two key effector cells in allergic inflammationQ37480813
CD48: A co-stimulatory receptor of immunityQ37787551
Targeted therapy of bronchitis in obstructive airway diseasesQ38120928
Molecular targets on mast cells and basophils for novel therapiesQ38207295
Mast cells in asthma--state of the art.Q38633155
'Real-life' effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review.Q38661772
P433issue6
P921main subjectasthmaQ35869
P304page(s)888-895
P577publication date2016-12-01
P1433published inAllergyQ2699825
P1476titleCD48 on blood leukocytes and in serum of asthma patients varies with severity
P478volume72

Reverse relations

cites work (P2860)
Q42736759Asthma Biomarkers: Do They Bring Precision Medicine Closer to the Clinic?
Q33785627Eosinophil Activation Status in Separate Compartments and Association with Asthma
Q57300304Evaluation of Soluble CD48 Levels in Patients with Allergic and Nonallergic Asthma in Relation to Markers of Type 2 and Non-Type 2 Immunity: An Observational Study
Q59332892Highlights and recent developments in airway diseases in EAACI journals (2017)
Q50068947Human eosinophils and mast cells: Birds of a feather flock together
Q64078040Subversion of natural killer cell responses by a cytomegalovirus-encoded soluble CD48 decoy receptor

Search more.